4 completed. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 4 |
Follow ibutilide: new trials by email Literature Review of ibutilide trials Research Report on ibutilide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening Progesterone, Ibutilide, Testosterone - Long QT Syndrome, Abnormalities, Drug-Induced | Phase 4 | Completed | Indiana University | 73 | 2021-09-02 | 2026-10-20 |
| Reducing the Risk of Drug-Induced QT Interval Lengthening in Women Progesterone, Ibutilide - Long QT Syndrome, Abnormalities, Drug-Induced | Phase 4 | Completed | Indiana University | 27 | 2019-03-26 | 2025-07-01 |
| Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes Testosterone, Progesterone, Placebo - Long QT Syndrome | Phase 4 | Completed | Indiana University | 14 | 2016-05-01 | 2019-08-28 |
| Vernakalant Versus Ibutilide In Recent-Onset Atrial Fibrillation Brinavess (Vernakalant), Corvert (Ibutilide) - Atrial Fibrillation | Phase 4 | Completed | Medical University of Vienna | 101 | 2011-10-01 | 2015-05-13 |
Long QT Syndrome (3) · Abnormalities, Drug-Induced (2) · Atrial Fibrillation (1) · Risk Reduction Behavior (1) · Torsades de Pointes (1)
Indiana University (3) · Medical University of Vienna (1)
United States (3) · Austria (1)
R01HL153114 (1)